Family Heart Foundation Research Finds High-Risk Americans Who Do Not Maintain Guideline Recommended LDL-C Targets Have 44% Higher Rate of Cardiovascular Events
Findings Based on Real-World Analysis to be Presented at AMCP 2023
SAN ANTONIO, March 21, 2023 – A real-world, retrospective analysis … Read More →
Lipoprotein(a), also known as Lp(a), is an important genetic factor that can increase the risk of developing atherosclerosis (hardening of the arteries) and cardiac events, like heart attacks and strokes. It’s no wonder that when a person finds out they have an elevated Lp(a) level, they become … Read More →
928,741 Reasons to Care
Heart disease and stroke are often thought to be an inevitable facet of aging. This is a dangerous misperception that contributes to the fact that cardiovascular disease is still the #1 cause of disease and death in the United States today.
In fact, the disease process that … Read More →
March 4th saw the kickoff of the American College of Cardiology’s Annual Meeting in New Orleans. For three days, leading clinicians and organizations presented thought-provoking research in the world of cardiology. The Family Heart Foundation presented our research in a scientific poster during … Read More →
Breaking Down the Latest Family Heart Foundation Research
This week, the Family Heart Foundation team will present important new research at the 2023 American College of Cardiology Scientific Sessions in New Orleans. This analysis from the Family Heart DatabaseTM examines the state of LDL cholesterol … Read More →
Findings to be Presented at ACC Scientific Sessions Highlight Life-Threatening Gaps in Treatment
NEW ORLEANS, Feb. 28, 2023 – According to a new study from the Family Heart Foundation, a leading research and advocacy organization, 72.2% of high-risk hypercholesterolemia patients never achieve the … Read More →
On November 5th, in the company of leading pharmaceutical companies, healthcare systems, and researchers, we shared the amazing progress the Family Heart Foundation has made in its efforts to save generations of families affected by familial hypercholesterolemia (FH) and elevated Lipoprotein(a), also … Read More →
New Data and Findings
The American Heart Association’s (AHA) 2022 Scientific Session was held in Chicago from November 4-6. This is one of the premier scientific meetings of the year with over 10,000 clinicians and researchers in attendance, Sessions focused on the latest research and insights to … Read More →
In August of 2022, the American College of Cardiology (ACC) released an Expert Consensus Decision Pathway with new guidance for lowering LDL cholesterol.
An Expert Consensus Decision Pathway is a guiding tool for medical professionals. They are developed as new data and treatments are available, but … Read More →
Family Heart Foundation Study Shows Some Children With Homozygous Familial Hypercholesterolemia Miss Out On Decades Of Life-Saving Treatment
Only Children with the Most Severe HoFH are Diagnosed Before Adulthood, Putting those Not Identified Early at Risk for Heart Disease at a Young Age
New … Read More →
